D. Moss

发表

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

J. Burrows, S. Burrows, R. Khanna, 1994, The Journal of experimental medicine.

Targeting a Polyepitope Protein Incorporating Multiple Class II-Restricted Viral Epitopes to the Secretory/Endocytic Pathway Facilitates Immune Recognition by CD4+ Cytotoxic T Lymphocytes: a Novel Approach to Vaccine Design

Scott R. Burrows, Scott A. Thomson, Rajiv Khanna, 1998, Journal of Virology.

Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.

D. Moss, A. Suhrbier, L. Brown, 1998, Journal of immunology.

New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.

C. Rooney, D. Moss, L. Young, 1987, The Journal of general virology.

Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients.

D. Cooper, D. Moss, T. Sculley, 1992, AIDS research and human retroviruses.

Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences

M. Alpers, J. Burrows, S. Burrows, 1996, Journal of virology.

Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.

R. Brennan, John J Miles, J. Burrows, 2008, The Journal of infectious diseases.

Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination.

S. Burrows, D. Moss, M. Lavin, 1993, Journal of immunology.

Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

X. Mo, P. Doherty, D. Moss, 1996, Journal of immunology.

Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability

James McCluskey, Rajiv Khanna, Anthony W Purcell, 2010, Proceedings of the National Academy of Sciences.

Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition*

S. Burrows, R. Khanna, D. Moss, 2001, The Journal of Biological Chemistry.

47 – Epstein-Barr virus vaccines

D. Moss, V. Lutzky, 2013 .

Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine

D. Moss, S. Thomson, P. Crooks, 2009, Journal of Virology.

Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignancies

R. Khanna, D. Moss, M. Gandhi, 2005, Nature Clinical Practice Oncology.

Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.

D. Moss, J. Davis, 2004, Tissue antigens.

Adoptive transfer of autologous Epstein‐Barr virus–specific cytotoxic T cells for nasopharyngeal carcinoma

K. Yuen, D. Moss, D. Kwong, 2001, International journal of cancer.

Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720)

D. Moss, A. Suhrbier, S. Elliott, 1995, Journal of virology.

Strategies involved in developing an effective vaccine for EBV-associated diseases.

S. Burrows, R. Khanna, D. Moss, 1996, Advances in cancer research.

A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy

G. Dranoff, A. Kelso, S. Burrows, 1997, Cancer Immunology, Immunotherapy.

Selection Pressure-Driven Evolution of the Epstein-Barr Virus-Encoded Oncogene LMP1 in Virus Isolates from Southeast Asia

L. Bromham, J. Burrows, S. Burrows, 2004, Journal of Virology.

Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

S. Burrows, R. Khanna, D. Moss, 1994, International immunology.

EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.

S. Burrows, R. Khanna, D. Moss, 1993, Journal of Immunology.

Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma

M. Epstein, C. Rooney, D. Moss, 1985, International journal of cancer.

Paired epstein‐barr virus‐carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non‐specific and to allo‐specific cytotoxic responses in vitro

M. Epstein, C. Rooney, D. Moss, 1984, International journal of cancer.

Epstein‐Barr virus specific T‐cell response in nasopharyngeal carcinoma patients

S. Burrows, D. Moss, S. Chan, 1983, International journal of cancer.

EBV-Specific Immune Response: Early Research and Personal Reminiscences.

D. Moss, V. Lutzky, 2015, Current topics in microbiology and immunology.

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

S. Burrows, D. Moss, M. Gandhi, 2010, Blood.

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

S. L. Silins, R. Khanna, D. Moss, 2001, Blood.

Optimization of LMP‐specific CTL expansion for potential adoptive immunotherapy in NPC patients

D. Tscharke, D. Moss, Mark C. Smith, 2009, Immunology and cell biology.

Epstein–Barr virus: The future for screening, treatment and monitoring of nasopharyngeal carcinoma

D. Moss, Mark C. Smith, W. Coman, 2006 .

blood T-cell repertoire perturbations despite high levels of systemic viral load Asymptomatic primary Epstein-Barr virus infection occurs in the absence of

S. L. Silins, R. Khanna, D. Moss, 2013 .

Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis

S. L. Silins, J. Burrows, S. Burrows, 1996, The Journal of experimental medicine.

Differential Splicing of Antigen-Encoding RNA Reduces Endogenous Epitope Presentation That Regulates the Expansion and Cytotoxicity of T Cells1

S. L. Silins, S. Burrows, R. Khanna, 2000, The Journal of Immunology.

Cytotoxicity of T Cells Presentation That Regulates the Expansion RNA Reduces Endogenous Epitope Differential Splicing of Antigen-Encoding

S. L. Silins, S. Burrows, R. Khanna, 2000 .

Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants

A. McMichael, M. Epstein, D. Moss, 1981, European journal of immunology.

T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.

A. McMichael, M. Bonneville, D. Moss, 2006, International immunology.

Sequential appearance of Epstein–Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation

M. Epstein, D. Moss, A. Rickinson, 1981, Nature.

J. H. Pope, D. Moss, I. Misko, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Oligopeptide Induction of a Secondary Cytotoxic T‐cell Response to Epstein‐Barr Virus In Vitro

S. Burrows, D. Moss, I. Misko, 1991, Scandinavian journal of immunology.

Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.

J. Altman, L. Cooper, R. Khanna, 2001, International immunology.

Major histocompatibility complex: from genes to function.

R. Khanna, D. Moss, Denis J. Moss, 1999, Immunology today.

Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy.

Kwok-Hung Chan, R. Khanna, Corey Smith, 2012, Cancer research.

Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.

S. Burrows, L. Cooper, R. Khanna, 1997, International immunology.

An immunological basis for inhibition of transformation of human lymphocytes by EB virus

J. H. Pope, D. Moss, W. Scott, 1977, Nature.

Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti‐MA)

J. H. Pope, G. Klein, D. Moss, 1974, International journal of cancer.

A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.

S. L. Silins, D. Moss, I. Misko, 1998, The Journal of clinical investigation.

Inhibition of HLA B8-restricted recognition by unrelated peptides: evidence for allosteric inhibition.

S. Burrows, D. Moss, A. Suhrbier, 1991, Immunology letters.

T cell recognition of Epstein-Barr virus associated lymphomas.

D. Moss, M. Masucci, A. Rickinson, 1992, Cancer surveys.

Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design.

R. Khanna, D. Moss, M. Sherritt, 2001, Vaccine.

X-Linked Agammaglobulinemia Patients Are Not Infected with Epstein-Barr Virus: Implications for the Biology of the Virus

S. Burrows, R. Khanna, D. Moss, 1999, Journal of Virology.

Implications for the Biology of the Virus Are Not Infected with Epstein-Barr Virus : X-Linked Agammaglobulinemia Patients

S. Burrows, R. Khanna, D. Moss, 1998 .

Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation.

H. Balfour, R. Khanna, K. Hogquist, 2015, The Journal of infectious diseases.

Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction

H. Balfour, R. Khanna, K. Hogquist, 2015, Journal of Virology.

Use of CD107‐based cell sorting ex vivo to enrich subdominant CD8+ T cells in culture

D. Tscharke, D. Moss, L. Morrison, 2007, Immunology and cell biology.

Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells.

S. Burrows, L. Cooper, R. Khanna, 1998, Cancer research.

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus

S. L. Silins, J. Burrows, D. Moss, 1996, Journal of virology.

Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. II. Components necessary for regression in virus‐infected leukocyte cultures

J. H. Pope, D. Moss, A. Rickinson, 1979 .

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.

S. Sengupta, D. Moss, T. Sculley, 1994, The Journal of general virology.

Understanding human T‐cell‐mediated immunoregulation through herpesviruses

S. Burrows, R. Khanna, D. Moss, 2011, Immunology and cell biology.

Interleukin-1 beta-converting enzyme-like protease cleaves DNA- dependent protein kinase in cytotoxic T cell killing

D. Chan, E. Alnemri, J. Trapani, 1996, The Journal of experimental medicine.

Spontaneous apoptosis in NS-1 myeloma cultures: effects of cell density, conditioned medium and acid pH.

D. Moss, J. Kerr, R. Kluck, 1993, Immunobiology.

T lymphocyte lines from arthritic synovial fluid: establishment and function.

D. Moss, C. Bishop, J. Ryan, 1986, Annals of the rheumatic diseases.

Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants

S. L. Silins, J. Burrows, S. Burrows, 1996, Journal of virology.

Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution

J. Burrows, S. Burrows, R. Khanna, 1996, Journal of virology.

Requirements for Recognition of Epstein-Barr Virus-Infected Target Cells by Human Cytotoxic T Lymphocytes

D. Moss, A. Rickinson, C. Gregory, 1989 .

Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis

S. Burrows, R. Khanna, D. Moss, 2004, Springer Seminars in Immunopathology.

Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.

S. Burrows, R. Khanna, D. Moss, 1993, Journal of immunological methods.

Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.

S. Burrows, D. Moss, I. Misko, 1991, The Journal of general virology.

An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants

S. Burrows, D. Moss, I. Misko, 1990 .

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.

E. Kieff, S. Burrows, D. Moss, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Induction of Epstein-Barr virus nuclear antigens

J. H. Pope, D. Moss, T. Sculley, 1986, Journal of virology.

Solar and UVC-induced mutation in human cells and inhibition by deoxynucleosides.

D. Moss, P. Parsons, J. Staples, 1989, Mutation research.

Failure of Epstein‐Barr virus‐specific cytotoxic T lymphocytes to lyse B cells transformed with the B95‐8 strain is mapped to an epitope that associates with the HLA‐B8 antigen

S. Burrows, D. Moss, I. Misko, 1992, Clinical and experimental immunology.

Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells.

S. Burrows, L. Cooper, R. Khanna, 1997, Journal of immunology.

Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach

D. Moss, M. Bharadwaj, 2002, Expert review of vaccines.

Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytes

J. H. Pope, D. Moss, A. Rickinson, 1978, International journal of cancer.

Cell relationships in transformation of human leukocytes by epstein‐barr virus

J. H. Pope, D. Moss, W. Scott, 1974, International journal of cancer.

Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. IV. Development of T‐cell memory in convalescent infectious mononucleosis patients

J. H. Pope, D. Moss, N. Ahlberg, 1980, International journal of cancer.

Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response.

S. Burrows, R. Khanna, D. Moss, 1994, Ciba Foundation symposium.

Reactivation of epstein‐barr virus‐specific cytotoxic t cells by in vitro stimulation with the autologous lymphoblastoid cell line

M. Epstein, D. Moss, M. Rowe, 1981, International journal of cancer.

Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. III. Activation of cytotoxic T cells in virus‐infected leukocyte cultures

J. H. Pope, D. Moss, A. Rickinson, 1979, International journal of cancer.

B cells following recombinant vaccinia infection andtheir recognition byhumancytotoxic T cells

E. Kieff, S. Burrows, R. Khanna, 1991 .

Distribution of Epstein-Barr Virus Strains with Different EBNA 2 Genotypes in Burkitt-Endemic Areas

J. H. Pope, D. Moss, L. Young, 1987 .

Lymphokine‐activated killer (lak) cells discriminate between epstein‐barr virus (ebv)‐positive burkitt's lymphoma cells

S. Burrows, D. Moss, I. Misko, 1990, International journal of cancer.

Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1

John J Miles, S. Burrows, R. Khanna, 2004, The Journal of experimental medicine.

Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.

S. Burrows, D. Moss, P. Parsons, 1989, Pigment cell research.

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.

S. Burrows, R. Khanna, D. Moss, 1995, Virology.

A comparison of Epstein-Barr virus-specific T-cell immunity in rheumatoid arthritis and osteoarthritis patients.

S. Burrows, D. Moss, A. Klestov, 1983, The Australian journal of experimental biology and medical science.

Calcium concentration defines two stages in transformation of lymphocytes by epstein‐barr virus

S. Burrows, D. Moss, P. Parsons, 1984, International journal of cancer.

Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response.

M. Epstein, D. Moss, M. Rowe, 1982, Cellular immunology.

Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein‐Barr virus

S. Burrows, D. Moss, A. Suhrbier, 1992, European journal of immunology.

BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays.

S. Burrows, D. Moss, A. Suhrbier, 1991, Journal of immunological methods.

Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.

M. Epstein, C. Rooney, D. Moss, 1985, IARC scientific publications.

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy

Richard E. Slaughter, J. Burrows, R. Khanna, 2003, Transplantation.

Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation.

M. Epstein, D. Moss, M. Rowe, 1982, Cellular immunology.

Characterization of a novel monoclonal antibody, 3H‐1, reactive with squamoproliferative lesions and squamous‐cell cancers

D. Moss, P. Parsons, J. Kearsley, 1991, International journal of cancer.

Prognostic significance of monoclonal antibody 3H‐1 reactivity with squamous‐cell head‐and‐neck cancers

D. Moss, D. Battistutta, P. Parsons, 1991, International journal of cancer.

Narrowing of T‐cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients

S. L. Silins, R. Khanna, D. Moss, 2010, Immunology and cell biology.

Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.

D. Moss, P. Parsons, M. McEwan, 1988, The Journal of investigative dermatology.

Human malignant melanoma cell lines.

J. H. Pope, D J Moss, L. Morrison, 1979, Pathology.

S. Burrows, R. Khanna, D. Moss, 2022 .

Long-term T-cell-mediated immunity to Epstein-Barr virus.

J. H. Pope, M. Epstein, D. Moss, 1981, Cancer research.

Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity

J. McCluskey, S. L. Silins, J. Burrows, 1997, European journal of immunology.

Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro

M. Epstein, D. Moss, A. Rickinson, 1981, European journal of immunology.

Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism.

S. Burrows, R. Khanna, D. Moss, 1999, Blood.

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

S. Burrows, D. Moss, I. Misko, 1988, Nature.

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift

J. Burrows, S. Burrows, R. Khanna, 1997, Journal of virology.

Immune regulation in Epstein-Barr virus-associated diseases

R. Khanna, D. Moss, S. Burrows, 1995 .

A comparison of epstein‐barr virus‐specific T‐cell immunity in malaria‐endemic and ‐nonendemic regions of Papua New Guinea

J. H. Pope, M. Alpers, S. Burrows, 1983, International journal of cancer.

Decreased calcium dependence of lymphoblastoid cell lines compared with burkitt lymphoma cell lines

D. Moss, P. Parsons, K. Maynard, 1985, International journal of cancer.

Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies.

S. Burrows, R. Khanna, D. Moss, 1999, Journal of acquired immune deficiency syndromes.

Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

Andreas Suhrbier, John J Miles, S. Burrows, 2007, Journal of Virology.

LMP 1 in Virus Isolates from Southeast Asia Epstein-Barr Virus-Encoded Oncogene Selection Pressure-Driven Evolution of the

L. Bromham, J. Burrows, S. Burrows, 2004 .

Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.

S. Burrows, D. Moss, I. Misko, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Eb virus‐associated nuclear antigen production and cell proliferation in adult peripheral blood leukocytes inoculated with the qimr‐wil strain of eb virus

J. H. Pope, D. Moss, 1975, International journal of cancer.

Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis

J. H. Pope, D. Moss, P. Walker, 1984, Journal of virology.

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

E. Kieff, S. Burrows, R. Khanna, 1992, The Journal of experimental medicine.

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

Richard E. Slaughter, S. Burrows, R. Khanna, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.

D. Moss, A. Rickinson, 1997, Annual review of immunology.

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

Lisa M. Ebert, C. Gedye, D. Moss, 2008, Cancer research.

The influence of antiviral T-cell responses on the alloreactive repertoire.

S. L. Silins, S. Burrows, R. Khanna, 1999, Immunology today.

Detection of Epstein-Barr virus strain variants in lymphoblastoid cell lines 'spontaneously' derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls.

J. H. Pope, D. Moss, T. Sculley, 1987, The Journal of general virology.

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

D J Moss, E. Kieff, S. L. Silins, 1994, The Journal of experimental medicine.

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell‐mediated immune recognition of human melanoma cells

R. Tampé, P. van Endert, L. Cooper, 1998, International journal of cancer.

HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading.

P. Cresswell, J. McCluskey, S. Burrows, 1998, Immunity.

Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines

J. Neefjes, S. L. Silins, S. Burrows, 1997, Journal of virology.

The immunology of Epstein-Barr virus infection.

S. L. Silins, S. Burrows, R. Khanna, 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Vaccine strategies against Epstein‐Barr virus‐associated diseases: lessons from studies on cytotoxic T‐cell‐mediated immune regulation

S. Burrows, R. Khanna, D. Moss, 1999, Immunological reviews.

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expression

J. Trowsdale, S. Burrows, R. Khanna, 1995, European journal of immunology.

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

D. Cooper, D. Moss, Ann Apolloni, 1990, The Journal of infectious diseases.

T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen

S. L. Silins, S. Burrows, R. Khanna, 1995, The Journal of experimental medicine.

Human lymphoid cell transformation by Epstein-Barr virus.

J. H. Pope, D. Moss, W. Scott, 1973, Nature: New biology.

Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice

D. Tscharke, J. Sidney, A. Sette, 2006, Journal of Virology.

Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.

J. H. Pope, D J Moss, D. Moss, 1972, The Journal of general virology.

Promiscuous CTL Recognition of Viral Epitopes on Multiple Human Leukocyte Antigens: Biological Validation of the Proposed HLA A24 Supertype 1

Rajiv Khanna, John J Miles, J. Burrows, 2003, The Journal of Immunology.

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

D J Moss, R Khanna, S. Burrows, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Cytotoxic T Cell Adoptive Immunotherapy as a Treatment for Nasopharyngeal Carcinoma

D. Moss, B. Panizza, P. Crooks, 2013, Clinical and Vaccine Immunology.

Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.

Rekha Khanna, D. Moss, I. Misko, 1996, Virology.

Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.

E. Kieff, S. Burrows, R. Khanna, 1991, Immunology.

Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.

S. Burrows, R. Khanna, D. Moss, 1994, The Journal of general virology.

Immune surveillance against Epstein-Barr virus.

S. Burrows, R. Khanna, D. Moss, 1992, Seminars in immunology.

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

S. Burrows, D. Moss, I. Misko, 1990, The Journal of experimental medicine.

Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine

L. Cooper, R. Khanna, D. Moss, 2004, Cancer Research.

Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing.

S. Burrows, R. Khanna, D. Moss, 1992, Immunology.

Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.

S. L. Silins, J. Burrows, D. Moss, 1997, International immunology.

Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies

D J Moss, R Khanna, S. L. Silins, 1996, Journal of virology.

Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants.

S. Burrows, D. Moss, I. Misko, 1990, Cellular immunology.

The specificity of recognition of a cytotoxic T lymphocyte epitope

S. Burrows, D. Moss, A. Suhrbier, 1992, European journal of immunology.

T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism

S. Burrows, D. Moss, M. Lavin, 1991, The Journal of experimental medicine.

Biomarkers for Cancers of the Head and Neck

D. Moss, P. Parsons, G. Boyle, 2008 .

Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

D. Cooper, D. Moss, Ann Apolloni, 1989, Virology.

Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.

R. Khanna, T. Kotsimbos, D. Moss, 2004, International immunology.

Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.

P. Cresswell, S. Burrows, L. Cooper, 1997, Journal of immunology.

T lymphocytes in infectious mononucleosis. I. T cell death in vitro.

S. Burrows, D. Moss, C. Bishop, 1985, Clinical and experimental immunology.

T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines.

S. Burrows, D. Moss, C. Bishop, 1985, Clinical and experimental immunology.

Interleukin-2 receptors in infectious mononucleosis.

S. Burrows, D. Moss, I. Misko, 1989, Immunology letters.

Emerging Immunotherapeutics for the Treatment of Nasopharyngeal Carcinoma

D. Moss, M. Bharadwaj, M. Elliott, 2003 .

Immunobiology and host response

S. Burrows, R. Khanna, D. Moss, 2007 .

The use of T-cell directed cellular therapies in Australia.

R. Khanna, D. Moss, M. Gandhi, 2007, Cytotherapy.

Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.

D. Moss, I. Misko, T. Sculley, 1991, Cellular immunology.

Familial Burkitt's lymphoma in Papua New Guinea.

M. Alpers, C. Bain, D. Moss, 1997, British Journal of Cancer.

Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection.

J. Burrows, S. Burrows, R. Khanna, 2001, Blood.

Epstein–Barr virus T‐cell immunity despite rituximab

R. Khanna, D. Moss, M. Gandhi, 2007, British journal of haematology.

Identity of the soluble ebv‐associated antigens of human lymphoid cell lines

J. H. Pope, D. Moss, B. Reedman, 2006, International journal of cancer.

The Role of EBNA Proteins as a Target for EBV-Specific T Cell Lysis

S. Burrows, R. Khanna, D. Moss, 1991 .

Vaccines Against Human Hookworm Disease

S. Hoffman, D. Vaughn, R. Brunham, 2004 .

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

S. Burrows, D. Moss, I. Misko, 1990, The Journal of experimental medicine.

Candidate vaccines for Epstein-Barr virus

D. Moss, A. Suhrbier, S. Elliott, 1998, BMJ.

Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction

H. Balfour, R. Khanna, K. Hogquist, 2015, Journal of Virology.

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

S. L. Silins, S. Burrows, D. Moss, 1994, The Journal of experimental medicine.

Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability

T. Beddoe, J. McCluskey, J. Rossjohn, 2010, Proceedings of the National Academy of Sciences.

Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis

S. L. Silins, J. Burrows, S. Burrows, 1996, The Journal of experimental medicine.

In Vitro Immunogenicity of Human Lymphoid Tumour Cell Lines

S. Burrows, D. Moss, T. Sculley, 1985 .

Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy.

Kwok-Hung Chan, R. Khanna, Corey Smith, 2012, Cancer research.

Developing vaccines against EBV-associated diseases

S. Burrows, R. Khanna, D. Moss, 2005 .